Position in MRK
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$159,102,049
+$24,823,236 QoQ
Shares Held
1,322,654
+3.7% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Candriam S.C.A. holds $1,534,786,576 across 9 Drug Manufacturers - General names. MRK ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
417,282 | $383,803,465 | |
| 2 | ABBV |
AbbVie Inc.
|
1,144,668 | $248,953,843 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
1,670,288 | $232,788,038 | |
| 4 | JNJ |
Johnson & Johnson
|
798,815 | $195,262,338 | |
| 5 | MRK |
Merck & Co., Inc.
This page
|
1,322,654 | $159,102,049 | |
| 6 | AMGN |
Amgen Inc
|
395,351 | $139,104,249 | |
| 7 | BIIB |
Biogen Inc.
|
381,768 | $69,989,527 | |
| 8 | PFE |
Pfizer Inc
|
1,992,586 | $55,951,814 |
All Filings in MRK
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $159,102,049 | 1,322,654 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $134,278,813 | 1,275,687 | Shares | Sole | 2026-04-30 | |
| 2025-09-30 | $119,110,182 | 1,419,161 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $130,938,476 | 1,654,099 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $192,848,282 | 2,148,488 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $220,589,239 | 2,217,423 | Shares | Other | 2025-02-07 | |
| 2024-09-30 | $280,006,481 | 2,465,714 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $294,701,566 | 2,380,465 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $326,355,893 | 2,473,330 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $330,362,106 | 3,030,289 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $343,399,916 | 3,335,599 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $360,705,792 | 3,125,971 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $369,179,895 | 3,470,062 | Shares | Other | 2023-05-12 | |
| 2022-12-31 | $355,671,526 | 3,205,692 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $299,573,414 | 3,478,558 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $317,457,403 | 3,482,038 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $290,467,584 | 3,540,129 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $203,314,806 | 2,652,855 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $275,141,374 | 3,663,179 | Shares | Other | 2021-11-09 | |
| 2021-06-30 | $335,834,735 | 4,318,307 | Shares | Other | 2021-07-20 | |
| 2021-03-31 | $268,978,115 | 3,656,621 | Shares | Other | 2021-04-29 | |
| 2020-12-31 | $285,411,388 | 3,656,617 | Shares | Other | 2021-01-22 | |
| 2020-09-30 | $232,244,435 | 2,934,202 | Shares | Other | 2020-10-19 | |
| 2020-06-30 | $150,422,263 | 2,038,568 | Shares | Sole | 2020-07-23 | |
| 2020-03-31 | $102,315,693 | 1,393,643 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||